Patricia Decker, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 103 W South St, Flanagan, IL 61740 Phone: 815-796-4591 Fax: 815-796-4212 |
News Archive
A significant percentage of patients undergoing targeted CT of the heart have abnormalities outside the coronary arteries, some of which could be life threatening, and as a result need the experience of trained radiologists to interpret them, say researchers from the University of Michigan Cardiovascular Center in Ann Arbor.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today introduced Medidata Balanceā¢, a new randomization and trial supply management (RTSM) solution for clinical research sponsors and sites.
The Redsense safety device is the only device cleared by FDA to monitor patients for potential blood loss from the hemodialysis needle puncture site. With an 8 hour FDA clinical clearance, Redsense is available to help protect patients undergoing treatment in clinics for longer than 5 hours - such as Nocturnal Dialysis.
› Verified 9 days ago